ACAD Next Earnings Date Notes

— ACADIA Pharmaceuticals (NASDAQ: ACAD) is a biopharmaceutical company focused on developing & commercializing innovative medicines that address unmet medical needs in central nervous system (CNS) disorders. Its flagship product is NUPLAZID—the first & only FDA-approved treatment for hallucinations & delusions associated with Parkinson's disease psychosis. ACADIA is also advancing a pipeline in Alzheimer's disease psychosis (notably with NUPLAZID), Rett syndrome (with DAYBUE), & other potential CNS targets. For long-term investors, core business metrics include product revenue growth (especially NUPLAZID & the adoption ramp of DAYBUE), progress of key pipeline assets through clinical stages, profitability trends (R&D & SG&A expenses), and cash runway. Market expansion opportunities, label expansion achievements, and updates on collaborations or licensing agreements are also crucial. When listening to the earnings call, pay close attention to management's commentary on prescription trends, guidance updates, progress with regulatory submissions or approvals, and insights into competitive positioning within the neuropsychiatric treatment market. These factors collectively shape ACADIA's future growth prospects & valuation trajectory. The next projected earnings date for ACAD is 11/4/2026 after close (stay tuned for a confirmed earnings date once announced).

ACAD Next Earnings Date FAQ

On this page we presented the ACAD Next Earnings Date information for ACADIA Pharmaceuticals along with recent past earnings dates. For Q2 of 2026, ACAD reported earnings of 0.180/share, with the earnings report taking place on 8/4/2026. For Q1 of 2026, ACAD reported earnings of 0.020/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, ACAD reported earnings of 0.140/share, with the earnings report taking place on 2/25/2026. For Q3 of 2025, ACAD reported earnings of 0.260/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, ACAD reported earnings of 0.160/share, with the earnings report taking place on 8/6/2025. Based on these past earnings dates, the projected next earnings date for ACAD is 11/4/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as ACADIA Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to ACADIA Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research ACADIA Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next ACAD earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ACAD's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ACAD next earnings date.